Updated Jul 16, 2026
Remmel H. Lawrence has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Remmel H. Lawrence is identified in SEC filings as an individual associated with Atossa Therapeutics, Inc. as of May 14, 2026. The filings do not specify his exact title or role within the company, and there is no widely published biographical information available from publicly accessible sources based solely on the provided context. This entry reflects the SEC context rather than a detailed public biography.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | ATOS | ATOSSA THERAPEUTICS, INC. | A — Grant or award | 10.0K | $0.00 |
Remmel H. Lawrence is identified in SEC filings as an individual associated with Atossa Therapeutics, Inc. as of May 14, 2026. The filings do not specify his exact title or role within the company, and there is no widely published biographical information available from publicly accessible sources based solely on the provided context. This entry reflects the SEC context rather …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Remmel H. Lawrence profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.